Literature DB >> 19679424

In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

Christopher D Owens1, Nicole Wake, Michael S Conte, Marie Gerhard-Herman, Joshua A Beckman.   

Abstract

OBJECTIVE: As in arteries, venous endothelium modulates vessel homeostasis and tone. The effect of an arterialized environment on venous endothelial function remains poorly understood. In particular, regulation of saphenous vein graft (SVG) blood flow and lumen caliber remains undefined. We hypothesized that mature SVGs would exhibit endothelium-dependent, flow-mediated vasodilation (FMD). We further hypothesized that endothelium-derived nitric oxide (NO) was an important mediator.
METHODS: Patients with femoral to popliteal artery SVGs that had maintained primary patency and were at least 1 year from surgery were enrolled. High-resolution, B-mode ultrasound scans were used to measure vein graft diameter before and 1 minute after reactive hyperemia (RH) to determine FMD. RH was created through application of 220 mm Hg to the calf for 5 minutes with a sphygmomanometric cuff. After a 10-minute recovery period, nitroglycerin-mediated, endothelium-independent vasodilation was measured 3 minutes after administration of nitroglycerin 0.4 mg sublingually. Brachial artery FMD was determined by validated techniques. L-N(G)monomethyl arginine (L-NMMA; 1 mg/kg infusion over 10 minutes) was used in a subset of patients (n = 6) to competitively inhibit endothelial NO synthase.
RESULTS: Nineteen subjects were enrolled. The median age of the SVGs was 34.6 (21.0-49.7) months. SVG flow-mediated, endothelium-dependent vasodilation was measured at 5.28% +/- 3.1% mean change in lumen diameter (range, 1.99%-9.36%; P < .0001 for diameter change). Nitroglycerin-mediated vasodilation was 3.7% +/- 1.0%, (range, 16%-10.04%; P < .005). Intravenous administration of L-NMMA abolished SVG FMD (5.7 +/- 1.4% before L-NMMA vs 0.01 +/- 0.01% during L-NMMA infusion; P = .0088) and attenuated brachial artery FMD (7.54% +/- 1.0% vs 5.7 +/- 1.4; P = .05).
CONCLUSION: SVGs manifest flow-mediated, endothelium-dependent, and nitroglycerin-mediated endothelium-independent vasodilation. Vein graft endothelium-dependent FMD is likely mediated by NO. Further investigation will be required to determine the role of endothelial function in vein graft patency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679424      PMCID: PMC2783575          DOI: 10.1016/j.jvs.2009.06.022

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  38 in total

1.  Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness.

Authors:  Christopher D Owens; Nicole Wake; Jeffrey G Jacot; Marie Gerhard-Herman; Peter Gaccione; Michael Belkin; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2006-08-22       Impact factor: 4.268

2.  Endothelium-dependent and endothelium-independent flow regulation in coronary vascular regions supplied by arterial and venous bypass grafts.

Authors:  A Hartmann; T Lahoda; W Burger; F Beyersdorf; R Schräder; P Satter
Journal:  Cardiology       Date:  1997 Sep-Oct       Impact factor: 1.869

3.  Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease.

Authors:  E H Lieberman; M D Gerhard; A Uehata; A P Selwyn; P Ganz; A C Yeung; M A Creager
Journal:  Am J Cardiol       Date:  1996-12-01       Impact factor: 2.778

4.  Vein graft harvesting induces inflammation and impairs vessel reactivity.

Authors:  Kazuhiro Hinokiyama; Guro Valen; Shinichi Tokuno; Jenny Bäcklund Vedin; Jarle Vaage
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

5.  Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production.

Authors:  Michael R Dashwood; Kay Savage; Audrey Dooley; Xu Shi-Wen; David J Abraham; Domingos S R Souza
Journal:  Ann Thorac Surg       Date:  2005-09       Impact factor: 4.330

6.  Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production.

Authors:  Ada W Y Chung; Pooja Rauniyar; Honglin Luo; York N Hsiang; Cornelis van Breemen; Elena B Okon
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

7.  Close relation of endothelial function in the human coronary and peripheral circulations.

Authors:  T J Anderson; A Uehata; M D Gerhard; I T Meredith; S Knab; D Delagrange; E H Lieberman; P Ganz; M A Creager; A C Yeung
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

8.  Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans.

Authors:  M Kooijman; D H J Thijssen; P C E de Groot; M W P Bleeker; H J M van Kuppevelt; D J Green; G A Rongen; P Smits; M T E Hopman
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

9.  Importance of measuring the time course of flow-mediated dilatation in humans.

Authors:  Mark A Black; N Timothy Cable; Dick H J Thijssen; Daniel J Green
Journal:  Hypertension       Date:  2007-12-17       Impact factor: 10.190

10.  Endothelium-dependent responses in long-term human coronary artery bypass grafts.

Authors:  D D Ku; J B Caulfield; J K Kirklin
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  17 in total

1.  Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.

Authors:  Jessica Milian; Allison B Goldfine; Jonah P Zuflacht; Caitlin Parmer; Joshua A Beckman
Journal:  Acta Diabetol       Date:  2015-01-08       Impact factor: 4.280

2.  Measurement of brachial artery endothelial function using a standard blood pressure cuff.

Authors:  Jonathan S Maltz; Geoffrey H Tison; Hugh F Alley; Thomas F Budinger; Christopher D Owens; Jeffrey Olgin
Journal:  Physiol Meas       Date:  2015-09-22       Impact factor: 2.833

3.  Metabolomics reveals the impact of Type 2 diabetes on local muscle and vascular responses to ischemic stress.

Authors:  Joshua A Beckman; Jiun-Ruey Hu; Shi Huang; Eric Farber-Eger; Quinn S Wells; Thomas J Wang; Robert E Gerszten; Jane F Ferguson
Journal:  Clin Sci (Lond)       Date:  2020-09-18       Impact factor: 6.124

4.  n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.

Authors:  S Marlene Grenon; Christopher D Owens; Hugh Alley; Karen Chong; Priscilla K Yen; William Harris; Millie Hughes-Fulford; Michael S Conte
Journal:  Vasc Med       Date:  2013-09-19       Impact factor: 3.239

5.  Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).

Authors:  Joel L Ramirez; Warren J Gasper; Sukaynah A Khetani; Greg J Zahner; Nancy K Hills; Pete T Mitchell; Brian E Sansbury; Michael S Conte; Matthew Spite; S Marlene Grenon
Journal:  J Surg Res       Date:  2019-02-13       Impact factor: 2.192

6.  Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.

Authors:  S Marlene Grenon; Michael S Conte; Emily Nosova; Hugh Alley; Karen Chong; William S Harris; Eric Vittinghoff; Christopher D Owens
Journal:  J Vasc Surg       Date:  2013-07-02       Impact factor: 4.268

Review 7.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

Review 8.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

Review 9.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

Review 10.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.